TRVI — Trevi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Trevi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57.3	45	36.8	121	83
Net Total Receivables	0.558	0.265	0.241	1.31	0.955
Prepaid Expenses
Total Other Current Assets
Total Current Assets	59.6	46.3	38	123	87.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.43	0.33	0.184	0.194	1.56
Other Long Term Assets
Total Assets	60	47.1	38.5	123	89.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	5.2	5.55	12.7	13.4	5.82
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.46	19.8	21.4	15.6	6.86
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	54.5	27.3	17.1	107	82.5
Total Liabilities & Shareholders' Equity	60	47.1	38.5	123	89.4
Total Common Shares Outstanding